You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Antimicrobial resistance in Nigeria: challenges and charting the way forward
  1. Chinonyerem O. Iheanacho1,
  2. Uchenna I. H. Eze2
  1. 1 Department of Clinical Pharmacy and Public Health, Faculty of Pharmacy, University of Calabar, Calabar, Cross River State, Nigeria
  2. 2 Department of Clinical Pharmacy and Biopharmacy, Faculty of Pharmacy, Olabisi Onabanjo University, Ago Iwoye, Ogun State, Nigeria
  1. Correspondence to Pharm. Chinonyerem O. Iheanacho, Department of Clinical Pharmacy and Public Health, Faculty of Pharmacy, University of Calabar, Calabar, Cross River State, Nigeria; nonye2m{at}yahoo.com

https://doi.org/10.1136/ejhpharm-2021-002762

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Antimicrobial resistance (AMR) occurs when a normally active antimicrobial agent no longer shows activity against susceptible microbes. It is a threat to the control of emerging and increasing range of infections that result from microorganisms, and poses a risk of increased morbidity and mortality. Ranked among the top 10 global public health threats, AMR poses a threat to development, particularly in low and middle income countries such as Nigeria.1

    Nigeria is faced with the burden of poverty and poor environmental conditions such as lack of potable water and sanitation, and inadequate infection control. These factors are crucial in …

    View Full Text

    Footnotes

    • Contributors COI conceived and designed the study with substantial contribution from UIHE. Initial draft was done by COI and revised by UIHE. Both authors approve the manuscript for submission.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.